Skip to content

Clinical trials

Completed Bone Diseases, Metabolic trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bone Diseases, Metabolic Status: Completed Country / region: France Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20062
20092
20102
20123
20192
20213

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
Institut National de la Santé Et de la Recherche Médicale, France2
AstraZeneca1
CHU de Reims1
Centre Hospitalier Régional d'Orléans1
Centre Hospitalier Universitaire de Saint Etienne1
Eli Lilly and Company1
Hospices Civils de Lyon1
Lesieur1
Nantes University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bone Diseases, Metabolic16
Osteoporosis7
Breast Neoplasms3
Osteoporosis, Postmenopausal2
Anemia, Sickle Cell1
Bone Diseases1
Cataract1
Diabetes Mellitus1
Diabetes Mellitus, Type 11
Diabetes Mellitus, Type 21

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.